TP53 and vitiligo: The results showed that high CKS2 expression could inhibit the activity of P53 and participate in the progression of liver cancer.[14] In patients with vitiligo, Ultraviolet B (UVB) radiation is a commonly accepted treatment for patients with vitiligo.